FDA Panel Reviews First mRNA-Based Flu Vaccine Candidate
The U.S. Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee has begun reviewing a first-of-its-kind flu vaccine that utilizes messenger RNA (mRNA) technology.
mRNA vaccines work by instructing cells to produce proteins that trigger an immune response, teaching the body to recognize and fight